Invicta Animal Health has been appointed exclusive UK distributor of EquiChek, a rapid screening test which uses whole blood to assess the level of Serum Amyloid A (SAA), a major acute phase protein of inflammation in horses.

According to the company, EquiChek is the first test which is able to provide a visual semi-quantitative result within 15 minutes. The test will display 4 lines for a normal level of SAA and sequentially fewer lines depending on the severity of the inflammation.

Rob Watkins, Managing Director of Invicta, said: "Monitoring SAA levels in horses is a well-documented method of indicating a variety of conditions and for assessing health/inflammatory status prior to performance. However, the needs for equipment and time to perform the tests have always limited the situations in which it can be used.

"EquiChek changes all that. A stableside test for SAA means that monitoring real-time becomes a reality. Whether for tailoring antibiotic therapy, to check pre-breeding health status through to pre-competition health assessment, the applications are literally endless".

For further information see www.invictavet.com  or phone 01403 791313

PS: Whilst you're here, take a moment to see our latest job opportunities for vets.